HIGHLIGHTS
- who: A. Luna from the (UNIVERSITY) have published the Article: Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia, in the Journal: (JOURNAL)
- what: The study was approved by the Spanish Drug Agency and the Ethics Committee of the Hospital Universitario Ramón y Cajal (Madrid, Spain), with informed consent being obtained from all patients.
- future: Future directions to tackle this issue may include combinations of ponatinib and asciminib to maximize efficacy in these patients.
SUMMARY
Unfortunately, an important proportion of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.